Interleukin enhancer-binding factor 3 (ILF3) (C-Term) Peptid
ILF3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Interleukin enhancer-binding factor 3 (ILF3) Produkte
- Interleukin enhancer-binding factor 3 (ILF3)
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SYNPGSHGGY GGGSGGGSSY QGKQGGYSQS NYNSPGSGQN YSGPPSSYQS
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ILF3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Interleukin enhancer-binding factor 3 (ILF3)
- Hintergrund
- Protein Size: 894
- Gen-ID
- 3609
- NCBI Accession
- NP_001131145
- UniProt
- Q12906
-
Sie sind hier:
